Compare ASMB & OIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | OIS |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 682.7M |
| IPO Year | 2010 | 2000 |
| Metric | ASMB | OIS |
|---|---|---|
| Price | $29.44 | $11.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $44.20 | $14.00 |
| AVG Volume (30 Days) | 70.0K | ★ 782.9K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,088,133,000.00 |
| Revenue This Year | N/A | $3.73 |
| Revenue Next Year | $235.63 | $5.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 62.26 |
| 52 Week Low | $9.68 | $3.33 |
| 52 Week High | $39.71 | $14.50 |
| Indicator | ASMB | OIS |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 43.89 |
| Support Level | $29.31 | $5.72 |
| Resistance Level | $30.54 | $12.79 |
| Average True Range (ATR) | 1.44 | 0.49 |
| MACD | 0.10 | -0.09 |
| Stochastic Oscillator | 68.18 | 21.04 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.